Liver Cancer and Immunotherapy in the Liquid Biopsy Era
Abroad (travel likely)Recruiting
Conditions
Hepatocellular Carcinoma · BCLC Stage B Hepatocellular Carcinoma · BCLC Stage C Hepatocellular Carcinoma · Immune Checkpoint Inhibitor · Liquid Biopsy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU Montpellier, Montpellier, France
Contact: Study coordinator (Thomas BARDOL, M.D.)
Study leads
Catherine Alix-Panabières, Ph.D.
Study Director
University Hospital, Montpellier
Thomas Bardol, M.D.
Principal Investigator
University Hospital, Montpellier